Search results
Author(s):
Niek EG Beurskens
,
Fleur VY Tjong
,
Reinoud Knops
Added:
3 years ago
Since its introduction in 2012, leadless pacemaker (LP) therapy has developed as a therapeutic alternative to conventional transvenous pacemaker (PM) therapy to circumvent lead- and pocket-related complications.1-4 To date, two LPs are available for patients with a single-chamber pacing (VVI) indication: the Nanostim Leadless Cardiac Pacemaker (LCP; Abbott) and the Micra Transcatheter Pacing…
View more
Author(s):
Henry Chubb
,
Mark O’Neill
,
Eric Rosenthal
Added:
3 years ago
Device therapy is increasingly employed in the management of complex congenital heart disease (CHD). Bradycardias, most often related to sinus nodal dysfunction (SND) or atrioventricular nodal (AVN) block, may necessitate the implantation of pacing devices, while malignant arrhythmias may be treated by appropriate use of implantable cardioverter defibrillators (ICDs). However, there is a complex…
View more
Author(s):
Paul Roberts
,
Mohamed Hassan ElRefai
,
Paul Foley
,
et al
Added:
1 year ago
Author(s):
Mark Young Lee
,
Srinath Chilakamarri Yeshwant
,
Sreedivya Chava
,
et al
Added:
3 years ago
Aortic stenosis (AS) is the most common valvular heart disease in industrialised countries with a prevalence of about 5 % in the general population aged greater than 75 years. During the past decade, transcatheter aortic valve replacement (TAVR) has emerged as a valuable, minimally invasive treatment option for patients presenting with symptomatic severe AS, who due to their advanced age and…
View more
Author(s):
Khaldoun G Tarakji
,
Christopher R Ellis
,
Pascal Defaye
,
et al
Added:
3 years ago
Over the last few decades an increasing body of evidence has supported the role of cardiovascular implantable electronic devices (CIEDs) including permanent pacemakers (PPMs), implantable cardioverter-defibrillators (ICDs) and cardiac resynchronisation therapy (CRT-D [with defibrillator] and CRT-P [without defibrillator]) in improving quality of life and survival.1 In addition, there has been a…
View more
Author(s):
Adryan A Perez
,
Frank W Woo
,
Darren C Tsang
,
et al
Added:
3 years ago
The use of cardiovascular implantable electronic devices (CIEDs) has increased dramatically, with approximately 1.2–1.4 million CIEDs implanted annually worldwide.1 In the US alone, there are more patients with CIEDs than registered nurses.2,3 CIEDs use leads that connect a generator to cardiac tissue to treat patients with many conditions including symptomatic bradycardia, morbid tachycardia…
View more
Author(s):
Robert Sheldon
Added:
5 years ago
ProfessorRobert S. Sheldon discusses arandomized pragmatic trial of strategies of permanent pacemaker versus implantable cardiac monitor in older patients with syncope and bifascicular block.
Filmed by Radcliffe Cardiology on-site at HRS 2018 in Boston, US.
View more
Author(s):
Luuk Heckman
,
Kevin Vernooy
Added:
2 years ago
Luuk Heckman, from the Prof. Kevin Vernooy’s group at the Maastricht University Medical Center, provides Arrhythmia Academy with an overview on the performing AV node ablation and left bundle branch area pacemaker implantation in a single procedure.
View more
Review of Leadless Pacing
Author(s):
Nadeev Wijesuriya
,
Felicity De Vere
,
Vishal Mehta
,
et al
Added:
11 months ago
Article
Author(s):
Mark Elliott
,
Sheikh Momin
,
Barnaby Fiddes
,
et al
Added:
3 years ago
Deep brain stimulation (DBS) is an expanding neurosurgical treatment for refractory neurological conditions such as Parkinson’s disease and essential tremor, with over 120,000 devices implanted worldwide.1 The rate of cardiac implantable electronic device (CIED) implantation is rising annually, with 739 pacemaker implants per million and 141 ICD implants per million in western Europe in 2015.2…
View more